Chronic ehrlichiosis with pancytopenia: prognosis and management
8-year-old German Shepherd with ehrlichiosis diagnosed a year ago and left untreated, now with weakness, pale mucous membranes, petechiae and fever. Severe pancytopenia (haematocrit 14%, white cells 1,500/µL, platelets 8,000/µL) and hypoplastic bone marrow.
Which statement about prognosis and management is correct?
chevron_right Show answer and explanation
A. With doxycycline platelets normalise within a few days, just as in the acute phase
A rapid response is typical of the acute phase. In the chronic phase with a hypoplastic marrow, recovery is slow or does not occur.
B. Imidocarb is preferable to doxycycline in the chronic phase
There is no evidence that imidocarb is effective against Ehrlichia canis; doxycycline remains the antimicrobial of choice in all phases.
C. Doxycycline must be stopped because it is myelotoxic
Doxycycline is not myelotoxic and is the aetiological treatment. The cause of the pancytopenia is the chronic infection itself.
D. The prognosis is guarded to poor: besides doxycycline, it needs support (transfusions and control of secondary infections) and marrow recovery may take months or never happen
Correct. Pancytopenia with marrow hypoplasia marks the severe chronic phase, with high mortality from bleeding and sepsis. German Shepherds are predisposed to this form.
lightbulb Key takeaway
The best tool against chronic ehrlichiosis is prevention: continuous tick control, early diagnosis and treating dogs with abnormalities in the acute or subclinical phase with doxycycline. When faced with pancytopenia, be realistic with the owner about cost and prognosis.
Test yourself with 10 random questions
Infectious diseases · 100 questions, a different test every time
Related questions
Updated: October 31, 2026 · Educational content for veterinary professionals. It does not replace current clinical guidelines or the judgement of the attending veterinarian.